Emily M Hsieh1, Christoph P Hornik2, Reese H Clark3, Matthew M Laughon4, Daniel K Benjamin2, P Brian Smith2. 1. Duke-National University of Singapore Graduate Medical School, Singapore. 2. Duke University Medical Center, Duke Clinical Research Institute, Durham, North Carolina. 3. Pediatrix-Obstetrix Center for Research and Education, Sunrise, Florida. 4. Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina.
Abstract
OBJECTIVE: The aim of the article is to provide an update on medication use in infants admitted to the neonatal intensive care unit (NICU) in the United States and examine how use has changed over time. STUDY DESIGN: We performed a retrospective review (2005-2010) of a large prospectively collected administrative database. RESULT: Medications most commonly administered during the study period were ampicillin, gentamicin, caffeine citrate, vancomycin, beractant, furosemide, fentanyl, dopamine, midazolam, and calfactant (56-681 exposures per 1,000 infants). Those with the greatest relative increase in use included azithromycin, sildenafil, and milrinone. Medications with the greatest relative decrease in use included theophylline, metoclopramide, and doxapram. CONCLUSION: Medication use in the NICU has changed substantially over time, and only 35% of the most commonly prescribed medications are Food and Drug Administration -approved in infants. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
OBJECTIVE: The aim of the article is to provide an update on medication use in infants admitted to the neonatal intensive care unit (NICU) in the United States and examine how use has changed over time. STUDY DESIGN: We performed a retrospective review (2005-2010) of a large prospectively collected administrative database. RESULT: Medications most commonly administered during the study period were ampicillin, gentamicin, caffeine citrate, vancomycin, beractant, furosemide, fentanyl, dopamine, midazolam, and calfactant (56-681 exposures per 1,000 infants). Those with the greatest relative increase in use included azithromycin, sildenafil, and milrinone. Medications with the greatest relative decrease in use included theophylline, metoclopramide, and doxapram. CONCLUSION: Medication use in the NICU has changed substantially over time, and only 35% of the most commonly prescribed medications are Food and Drug Administration -approved in infants. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Authors: Daniel K Benjamin; Barbara J Stoll; Avory A Fanaroff; Scott A McDonald; William Oh; Rosemary D Higgins; Shahnaz Duara; Kenneth Poole; Abbot Laptook; Ronald Goldberg Journal: Pediatrics Date: 2006-01 Impact factor: 7.124
Authors: Robyn J Barst; D Dunbar Ivy; Guillermo Gaitan; Andras Szatmari; Andrzej Rudzinski; Alberto E Garcia; B K S Sastry; Tomas Pulido; Gary R Layton; Marjana Serdarevic-Pehar; David L Wessel Journal: Circulation Date: 2011-11-29 Impact factor: 29.690
Authors: David Kaufman; Robert Boyle; Kevin C Hazen; James T Patrie; Melinda Robinson; Leigh B Grossman Journal: J Pediatr Date: 2005-08 Impact factor: 4.406
Authors: Kevin J Downes; Molly Hayes; Julie C Fitzgerald; Gwendolyn M Pais; Jiajun Liu; Nicole R Zane; Stuart L Goldstein; Marc H Scheetz; Athena F Zuppa Journal: J Antimicrob Chemother Date: 2020-01-01 Impact factor: 5.790
Authors: Brian C Gulack; Matthew M Laughon; Reese H Clark; Meera N Sankar; Christoph P Hornik; P Brian Smith Journal: Early Hum Dev Date: 2015-09-19 Impact factor: 2.079
Authors: Dingwei Dai; James A Feinstein; Wynne Morrison; Athena F Zuppa; Chris Feudtner Journal: Pediatr Crit Care Med Date: 2016-05 Impact factor: 3.624